Treating Wegener's granulomatosis: how far have we come?
Hoffman
G S
GS
Department of Rheumatology, Cleveland Clinic Foundation, OH 44195.
D003520:Cyclophosphamide / Q000627:therapeutic use*; D014890:Granulomatosis with Polyangiitis / Q000628:therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D013256:Steroids / Q000627:therapeutic use*
D007155:Immunologic Factors; D013256:Steroids; D003520:Cyclophosphamide